![Phenomix Sciences](https://storage.googleapis.com/dealroom-images-production/c7/MTAwOjEwMDpjb21wYW55QHMzLWV1LXdlc3QtMS5hbWF6b25hd3MuY29tL2RlYWxyb29tLWltYWdlcy8yMDI0LzA1LzI0LzFlMTg1M2I2NWJiNGUwNTY0OTlkOGY2MDM3OGE5ZWM4.png)
Phenomix Sciences
VerifiedPhenomix Sciences an early-stage spinout of the Mayo Clinic focused on personalized treatments for chronic diseases.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$22—33m (Dealroom.co estimates May 2024.)
Saint Paul Minnesota (HQ)
Deals in current and previous year:
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
N/A | $0.0 | round | |
investor | $0.0 | round | |
N/A | $0.0 | round | |
investor investor investor | $0.0 | round | |
* | $2.3m | Grant | |
Total Funding | 000k |
Related Content
Recent News about Phenomix Sciences
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.